RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
RIN Institute's investors include Mitsubishi UFJ Capital, Fast Track Initiative, Inc., UTokyo Innovation Platform.
RIN Institute is headquartered in Tokyo, Japan.
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
RIN Institute is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RIN Institute — Funding & Investors." VCBacked, July 2, 2021, https://www.vcbacked.co/company/rin-institute. Accessed August 15, 2026.
VCBacked. (2021). RIN Institute — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/rin-institute
{{cite web |title=RIN Institute — Funding & Investors |url=https://www.vcbacked.co/company/rin-institute |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated